This is educational information, not medical advice, and The Peptide University does not sell peptides, supplies, or supplements. Many compounds discussed here are sold as “research chemicals” and are not approved for human use outside of clinical trials. Laws vary by country, and nothing here is a recommendation to obtain or use anything. Talk to a qualified clinician about your own situation.
MOTS-c is a mitochondrial-derived peptide (encoded in mitochondrial DNA rather than the cell nucleus). It's experimental, with no approved human use.
How it works
It acts as a metabolic regulator — research suggests it enhances fat use, improves glucose handling, and increases insulin sensitivity, partly by influencing energy-sensing pathways like AMPK.
The evidence
The strongest data is metabolic and preclinical — for example, marked improvements in insulin sensitivity in animal models. Human clinical evidence is still limited, so its real-world effects are unproven.
Safety
As a largely preclinical compound, its human safety profile is not established. “Promising in mice” is where it sits — interesting biology, unproven and unregulated in people.
FAQ
QWhat makes it unusual?
It's encoded by mitochondrial DNA, not nuclear DNA — a “mitochondrial-derived peptide,” a relatively new concept.
QIs it proven in humans?
No — most evidence is preclinical/metabolic; human data is limited.
Sources
This profile summarizes the following. Follow the links to read the originals — and remember that summaries age, so check for newer information.
Inclusion here is not endorsement of any source's claims; several are cited so you can compare how different outlets characterize the same evidence.
Questions & comments
No account, no login — leave a name or stay anonymous. Ask a question, add something the article missed, or answer someone else. Be kind and cite sources where you can.